NRX Pharmaceuticals, Inc. (NRXP)
3.42
-0.25
(-6.81%)
USD |
NASDAQ |
Aug 26, 12:39
NRX Pharmaceuticals 1 Year Total Returns (Daily) : 36.43% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 36.43% |
| August 24, 2026 | 30.68% |
| August 21, 2026 | 40.71% |
| August 20, 2026 | 33.97% |
| August 19, 2026 | 32.93% |
| August 18, 2026 | 24.64% |
| August 17, 2026 | 18.69% |
| August 14, 2026 | 22.47% |
| August 13, 2026 | 32.02% |
| August 12, 2026 | 40.59% |
| August 11, 2026 | 46.55% |
| August 10, 2026 | 32.94% |
| August 07, 2026 | 45.53% |
| August 06, 2026 | 25.87% |
| August 05, 2026 | 15.72% |
| August 04, 2026 | 12.13% |
| August 03, 2026 | 25.10% |
| July 31, 2026 | 17.10% |
| July 30, 2026 | 11.03% |
| July 29, 2026 | 12.15% |
| July 28, 2026 | 20.82% |
| July 27, 2026 | 21.00% |
| July 24, 2026 | 25.42% |
| July 23, 2026 | 35.64% |
| July 22, 2026 | 49.83% |
| Date | Value |
|---|---|
| July 21, 2026 | 49.66% |
| July 20, 2026 | 42.18% |
| July 17, 2026 | 40.92% |
| July 16, 2026 | 40.86% |
| July 15, 2026 | 43.41% |
| July 14, 2026 | 34.89% |
| July 13, 2026 | 29.28% |
| July 10, 2026 | 28.13% |
| July 09, 2026 | 22.32% |
| July 08, 2026 | 15.98% |
| July 07, 2026 | 23.44% |
| July 06, 2026 | 16.72% |
| July 02, 2026 | 16.57% |
| July 01, 2026 | 23.32% |
| June 30, 2026 | 25.46% |
| June 29, 2026 | 16.96% |
| June 26, 2026 | 6.57% |
| June 25, 2026 | 8.87% |
| June 24, 2026 | 10.56% |
| June 23, 2026 | 21.29% |
| June 22, 2026 | 19.63% |
| June 18, 2026 | 22.91% |
| June 17, 2026 | 19.16% |
| June 16, 2026 | 14.08% |
| June 15, 2026 | 18.60% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Eli Lilly & Co. | 78.54% |
| Pfizer Inc. | 21.65% |
| Oramed Pharmaceuticals, Inc. | 156.4% |
| Yarrow Bioscience, Inc. | 332.2% |
| ANI Pharmaceuticals, Inc. | -16.24% |